BE873853A - 5-phenyl-2-oxazolecarboximidamides - Google Patents

5-phenyl-2-oxazolecarboximidamides

Info

Publication number
BE873853A
BE873853A BE0/193200A BE193200A BE873853A BE 873853 A BE873853 A BE 873853A BE 0/193200 A BE0/193200 A BE 0/193200A BE 193200 A BE193200 A BE 193200A BE 873853 A BE873853 A BE 873853A
Authority
BE
Belgium
Prior art keywords
oxazolecarboximidamides
phenyl
Prior art date
Application number
BE0/193200A
Other languages
English (en)
French (fr)
Inventor
R White
Original Assignee
Morton Norwich Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morton Norwich Products Inc filed Critical Morton Norwich Products Inc
Publication of BE873853A publication Critical patent/BE873853A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE0/193200A 1978-02-27 1979-01-31 5-phenyl-2-oxazolecarboximidamides BE873853A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/881,827 US4151168A (en) 1978-02-27 1978-02-27 5-Phenyl-2-oxazole carboximidamides as antidepressants

Publications (1)

Publication Number Publication Date
BE873853A true BE873853A (fr) 1979-07-31

Family

ID=25379300

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/193200A BE873853A (fr) 1978-02-27 1979-01-31 5-phenyl-2-oxazolecarboximidamides

Country Status (15)

Country Link
US (1) US4151168A (xx)
JP (1) JPS54115371A (xx)
AU (1) AU518273B2 (xx)
BE (1) BE873853A (xx)
CA (1) CA1106385A (xx)
CH (1) CH638505A5 (xx)
DE (1) DE2907199A1 (xx)
ES (1) ES477715A1 (xx)
FR (1) FR2418229A1 (xx)
GB (1) GB2014988B (xx)
IE (1) IE47412B1 (xx)
IT (1) IT1115788B (xx)
MX (1) MX5082E (xx)
NL (1) NL190774C (xx)
SE (1) SE430063B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59135008U (ja) * 1983-02-28 1984-09-10 松下電工株式会社 分電盤装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL135043C (xx) * 1963-10-11
GB1075259A (en) * 1964-12-18 1967-07-12 Monsanto Chem Australia Ltd Novel substituted benzimidazoles and use therefor
FR1537684A (fr) * 1965-12-29 1968-09-07 Monsanto Chem Australia Ltd Procédé de préparation des 2-azolin-2-yl-benzimidazoles

Also Published As

Publication number Publication date
ES477715A1 (es) 1980-04-01
NL190774C (nl) 1994-08-16
AU518273B2 (en) 1981-09-24
NL190774B (nl) 1994-03-16
GB2014988A (en) 1979-09-05
IE782133L (en) 1979-08-27
MX5082E (es) 1983-03-14
IE47412B1 (en) 1984-03-07
US4151168A (en) 1979-04-24
IT1115788B (it) 1986-02-03
FR2418229B1 (xx) 1983-03-18
DE2907199A1 (de) 1979-08-30
JPS5523827B2 (xx) 1980-06-25
DE2907199C2 (xx) 1988-03-24
SE7811577L (sv) 1979-08-28
CA1106385A (en) 1981-08-04
AU4123278A (en) 1979-09-06
FR2418229A1 (fr) 1979-09-21
SE430063B (sv) 1983-10-17
JPS54115371A (en) 1979-09-07
IT7947857A0 (it) 1979-02-01
CH638505A5 (de) 1983-09-30
NL7900239A (nl) 1979-08-29
GB2014988B (en) 1982-06-09

Similar Documents

Publication Publication Date Title
AT379079B (de) Akupunkturgeraet
AT370950B (de) Hoeschenwindel
BE875475A (fr) Iminoquinazolines
BE872071A (fr) Afdichtorgaan
FI793460A (fi) Lagringsmaterial foer vaermeenergi
AT365922B (de) Netzbett
BE874159A (fr) Thermoplongeur
AT374352B (de) Sportschuh
BE876059A (fr) Azolopyrimidinones
BE873461A (fr) Kleerhanger
AR218561A1 (es) Copoliester p-oxibenzoilico
FI793501A (fi) Kompositioner foer polyvinylklorid-hartsskum
ATA872778A (de) Uhrband
ATA26879A (de) B-ettbank
AT368010B (de) Rollskier
TR20531A (tr) Karbamoyl oksimiler
BE871213R (fr) Arylmalonamido-1-oxadethiacephalosporines
AR224881A1 (es) 2-hidroxifenilbenzotiazoles
AT355471B (de) Schipresse
ATA510278A (de) Griffel
ATA562378A (de) Handgranate
AT376331B (de) Umpolmodulator
AT361359B (de) Skistock
AT357332B (de) Fraeser
BE869882A (fr) Vibropuncteur

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: NORWICH EATON PHARMACEUTICALS INC.

Effective date: 19990131